Clearmind Medicine Inc. Purchase Of Exploration And Evaluation Assets
Clearmind Medicine Inc. (CMND) reported Purchase Of Exploration And Evaluation Assets of CAD 10.00 thousand for the 12-month period ending 2021-10-31, per its 20-F filed 2023-02-06.
Discontinued › Notes
ifrs-full:PurchaseOfExplorationAndEvaluationAssets · last filed 2024-03-18
CAD
| Period end | Purchase Of Exploration And Evaluation Assets 12 month |
|---|---|
| 2021-10-31 | 10.00K CAD 20-F · filed 2023-02-06 |
| 2020-10-31 | 10.00K CAD 20-F · filed 2023-02-06 |
USD
| Period end | Purchase Of Exploration And Evaluation Assets 12 month |
|---|---|
| 2021-10-31 | $7.33K 20-F/A · filed 2024-03-18 |